Top compounds associated with response to CT47A2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.2
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA L-685458 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.059 0.2
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA ML006 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.073 0.2
Download CSV